ABSTRACT. Nonadherence to immunosuppressant medications leading onto poor graft outcome is frequent among renal transplant recipients. In this study, we sought to assess the prevalence and correlates of nonadherence to immunosuppressants and its impact on graft function. A singlecenter, retrospective cum cross-sectional study of renal transplant recipients of age >18 years and who had completed at least six months after transplantation was performed. Nonadherence was assessed based on the Immunosuppressant Therapy Adherence Scale questionnaire. Factors attributed to nonadherence were assessed based on the Immunosuppressant Therapy Barriers Scale (ITBS) questionnaire. Social, economic, demographic data, and all transplant related information were recorded. Two hundred and seventy-nine patients were included in the study, of whom 78% were male. Median follow-up period was 46 months (interquartile range -24 months to 82 months). Seventy-four patients (26.5%) admitted nonadherence to immunosuppressants. The nonadherence was significantly related to the male gender, late acute rejection episodes, rise in serum creatinine from > 0.5 mg/dL from nadir level, lower blood levels of calcineurin inhibitor, and higher ITBS scores. Refill rates and use of alarm reminders were not significantly associated with better adherence.
Introduction
Renal transplant remains the most satisfying treatment modality providing a better quality of life. The long-term survival depends on adherence to immunosuppressive medications.
Tielen et al's study on renal transplant recipients have shown that nonadherence to be related with allograft rejection, graft loss, and mortality. 5 Various published studies have revealed an estimated prevalence of nonadherence in 20%-50% of renal transplant recipients. 6 A study from Alabama, the USA has reported nonadherence to be the most common cause of preventable rejection episodes. 7 Chisholm et al reported that one in 10 deaths that occur in renal transplant recipients are due to medication nonadherence. 8 Life expectancy also reported to be four years less from the study done in Belgium. 9 Nonadherence to immunosuppressants cannot only cause acute rejection but also can lead to progressive graft dysfunction. In many nonadherent patients, graft histopathology has revealed significant interstitial fibrosis and tubular atrophy without any clinical features of acute rejection. 10 Availability of immunosuppressants that are highly efficacious to decrease the rejection episodes, has rendered the adherence to medications an essential role in the long-term outcome of transplant recipients.
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Various methods used to assess the nonadherence: 1. Electronic medication monitoring -gold standard for adherence measurement 12 2. Prescription "refill rate" and self-reporting of patients may underestimate nonadherence, but they are simple and commonly used assessment method 10, 13 3. Drug level monitoring has variable correlation with compliance and tends to overestimate nonadherence.
14 Self-reporting of patients to assess adherence is preferable since it is inexpensive and does not need invasive procedure and used to relate Immunosuppressive therapy (IST) adherence to patient-specific factors. 15 The Immunosuppressive Therapy Adherence Scale (ITAS) among solid organ transplants was found to have reliability, validity, and convergence. 16 There are several factors contributing to nonadherence of which majority of them are patient related. 17 IST adherence barriers scale (ITBS) is a reliable instrument which is useful in identifying these contributory factors and in formulating intervention strategies to improve the adherence rate among transplant recipients. 18, 19 Objectives of the study
In this study, we sought to assess the prevalence of nonadherence, to identify demographic and social correlates of nonadherence, to analyze the barriers to nonadherence, to study the impact of nonadherence on acute rejection episodes and chronic graft dysfunction, and to study the relation of nonadherence to immunosuppressant blood levels and medication refill records.
Methods
A retrospective cum cross-sectional study was performed in the outpatient transplant clinic of the Institute of Nephrology, Madras Medical College (MMC). A unique feature is that immunosuppressants are provided free of cost lifelong in all government institutions of Tamil Nadu including our center. The study was approved by the Institutional Ethics committee of MMC. Informed consent was obtained from all the study patients.
Eligibility criteria
Renal transplant recipients who have completed at least six months after transplant and those whose aged are >18 years were included in the study.
Exclusion criteria 1. Renal transplant recipient who have become dialysis dependent Demographic, laboratory, and medication data were collected. Demographic information included -age, gender, education level, marital status, and occupation. Transplantrelated data included transplant date and number, donor type, immunosuppressants, comorbidities, biopsy-proven rejection episodes after four months of transplant and medication refill records for the past three months. Laboratory information included serum creatinine, calci-neurin inhibitor (CNI) trough levels in the previous three months. The method used if any to get reminded about drug intake was also documented. The following two questionnaires in vernacular language were given and were explained as how to fill it. 1. Immunosuppressant therapy adherence scale, 2. Immunosuppressant therapy barrier scale.
Those people who were not literate enough to complete the questionnaire were instructed to get help from the relatives accompanying them.
Immunosuppressive Therapy Adherence Scale
It is a well-validated questionnaire to assess nonadherence, its frequency and gross reasons for nonadherence. 20 It consists of four items, namely (1) whether forget to take immunosuppressants, (2) omitted immunosuppressants due to carelessness, (3) omitted immunosuppressants due to perceived side effects, and (4) omitted immunosuppressants due to any other reason. Each item was scored from 0 to 3, total score of <12 was considered to be nonadherent.
Adherence was assessed for the period of preceding three months. Three months is often considered adequate for recognizing patterns of long-term medication adherence. 21 Ability to recall decreases beyond that three months which may impair the reliability of responses.
Immunosuppressant Therapy Barriers Scale
This 13-point questionnaire with 5-point Likert responses to assess the barriers and causes for nonadherence were also recorded Published studies revealed that three months refill rates of 90% or greater has significant correlation with other IST adherence markers; 22 hence, it was used as cutoff point for adherence based on immunosuppressant refill records. Medication refill rate was assessed by the observation of the patients' follow-up records. In our center, patients are provided immunosuppressants for 14 days during each visit. Hence, they are instructed to visit outpatient department every fortnight. Regarding CNI trough levels, cyclosporine <75 ng/mL, and tacrolimus <3 ng/mL were used as cutoff for assessing adherence. Lower concentration was used as a conservative approach to allow for the varying time after transplant. ITBS has been validated by various studies. 16 The IST adherence barriers were compared between adherent and nonadherent patients.
Statistical Analysis
Among the independent variables, categorical variables were listed as proportions between the groups and were compared using the Chisquare test. The continuous variables were listed as means with standard deviations and analyzed using Student's t-test of independent variables. Binary logistic regression model was used to assess the association between variables found to be significant by Chi-square or Student's t-test and nonadherence reported by the patient. Values of P <0.05 were considered statistically significant. Statistical Package for Social Sciences (SPSS) version 18.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis.
Results
We enrolled 279 renal allograft recipients who were willing to participate in the study. The mean age was 36 years ± 9 years, mean duration posttransplant was 4 years 8 months ± 3 years 3 months. Male-to-female ratio was 3.5:1, living donor transplants contributed to 70% of the total transplants. The mean serum creatinine was 1.41 ± 0.72 mg/dL. Among the participants 74 (26.52%) had selfreported nonadherence with ITAS score of <12. The various ITAS scores are depicted in Figure 1 . By statistical analysis using the Chi-square test and Student's t-test, the following factors were found to be significantly associated with nonadherence, namely male gender, rise in serum creatinine of >0.5 mg/dL from nadir value, late acute rejection episodes (>4 months after transplant), lower immunosuppressant blood levels (tacrolimus <3 ng/mL, cyclosporine porine <75 ng/mL), and higher number of barriers reported on ITBS score. One hundred and five patients reported the use of alarms set in their mobile phone as reminder to take immunosuppressants. Drug refill rate and reminder using mobile alarm were not associated with better adherence. The salient features of the study population and the relation to self-reported nonadherence are documented in Tables 1 and 2 .
Various barriers to intake of immunosuppression were reported by 129 (46%) of the patients. The percentage of the overall sample reporting difficulties in each barrier along with comparison to nonadherent cohorts is shown in Figure 2 . Among the overall sample which included both adherent and nonadherent patients, the most common barriers were too many dosages per day and too many medications at once.
Nonadherent patients had reported a higher number of barriers when compared to the adherent patients (P = 0.002), which was statistically significant. The following barriers were found to be significantly associated with nonadherence depicted in Table 3 .
The factors found to be statistically significant by initial analysis were further evaluated by binary logistic regression analysis. Nonadherence was significantly associated with higher ITBS scores. When late acute rejection episodes were evaluated as outcome they were significantly associated with nonadherent individuals who had 4-fold increased risk of having rejection episodes.
Discussion
Nonadherence to immunosuppressants is perceived as an important cause for poor graft outcome. The real magnitude of nonadherence is unknown. The study on adult renal transplant recipients revealed significant number of patients (one in four) had reported nonadherence to immunosuppression medications. The nonadherence was statistically associated with risk factors such as male gender, lower immunosuppressant concentration, and higher barriers to nonadherence. Nonadherence was also associated with outcomes such as late acute rejection episodes and late graft dysfunction. The patient's drug refill rate was not associated with nonadherence and also reminders for drug intake such as alarm mobile was also not significantly useful in increasing the adherence. Published studies from India regarding medication nonadherence are very limited. Sharma et al from Jaipur published a retrospective study of 152 patients, of which 21.7% of patients were nonadherent. 23 Another study from Adhikari et al showed the extent of nonadherence was 35%. 24 This study has the largest number (279) of patients with relatively longer time of followup when compared to other studies in evaluating nonadherence to immunosuppressants in renal transplant recipients. The study showed that despite medications being issued free for lifelong by the government, financial constraints were reported to be a significant barrier by nonadherent patients which may be because they are unemployed and also they had to travel long distance once in two weeks to get the immunosuppressants.
Vlaminck et al reported late acute rejection episodes are increased three-fold 25 and graft failure increased seven-fold in nonadherent individuals. 26 This study had similar results showing four-fold increased risk of late acute rejection episodes. The interventions which could be planned based on the results are reemphasize the patients during discharge and subsequent visits regarding medication adherence, routine evaluation whether the medications are being taken at an appropriate time without any confusion. Patients also should be advised to avoid unnecessary travel away from home, which also tends to increase the nonadherence.
Limitations of the study were it was singlecenter transplant study, whereas various factors may influence the occurrence of adherence in other centers, the study did not include patients who did not have functioning graft whose graft loss could have been due to nonadherence, moreover the study was cross section study analyzing nonadherence only during the past three months. Hence, it could have underestimated nonadherence.
There is urgent need for devising strategies to minimize nonadherence. Vigorous counseling before transplantation and periodically after transplantation on the potential risks of nonadherence has to be done. 
Conclusions
Nonadherence to immunosuppressants was prevalent in a significant number (26.5%) of the study population. Nonadherence was significantly associated with late rejection episodes and long-term graft function and lower immunosuppressant levels. Innovative measures have to be applied to overcome the barriers contributing to nonadherence. 
